Research ArticleNuclear Oncology
Monitoring Response to Therapy with Thallium-201 and Technetium-99m-Sestamibi SPECT in Nasopharyngeal Carcinoma
Lale Kostakoglu, Ugur Uysal, Enis Özyar, Mutlu Hayran, Dilek Uzal, Figen B. Demirkazïk, Ayse Kars, Lale Atahan and Coşkun F. Bekdik
Journal of Nuclear Medicine July 1997, 38 (7) 1009-1014;
Lale Kostakoglu
Ugur Uysal
Enis Özyar
Mutlu Hayran
Dilek Uzal
Figen B. Demirkazïk
Ayse Kars
Lale Atahan
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Monitoring Response to Therapy with Thallium-201 and Technetium-99m-Sestamibi SPECT in Nasopharyngeal Carcinoma
Lale Kostakoglu, Ugur Uysal, Enis Özyar, Mutlu Hayran, Dilek Uzal, Figen B. Demirkazïk, Ayse Kars, Lale Atahan, Coşkun F. Bekdik
Journal of Nuclear Medicine Jul 1997, 38 (7) 1009-1014;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Differentiating osteoradionecrosis from nasopharyngeal carcinoma tumour recurrence using 99Tcm-sestamibi SPECT/CT
- Interpretation of scintigraphic findings of oral malignant tumours with a new scanning agent of technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile (Tc-99m-MIBI)
- Scintigraphy for interpretation of malignant tumours of the head and neck: comparison of technetium-99m-hexakis-2-methoxyisobutylisonitrile (Tc-MIBI) and thallium-201-chloride (Tl-201)